baber/WOPTO huggingface dataset:
Patent CA-2323854-C (CA)
Title: A cab for earth-moving machines
Inventor: MURARO UMBERTO
IPC: E02F9/00
Filed: 2000-10-18
Granted: 2007-09-11
Abstract: A cab for earth-moving machines comprising a support structure, a control station for an operator obtained within the support structure, fastening means for fastening the support structure to a frame of an earth-moving machine, control means for controlling operative organs of the earth-moving machine positioned within the support structure in correspondence with the control station, and connecting means for operatively connecting the control means to the operative organs of the earth-moving machine. The connecting means comprise a plurality of hydraulic conduits connected to the control means and a plurality of semi-couplings connected to at least a portion of the plurality of hydraulic conduits and able to be coupled to a corresponding plurality of semi-couplings connected to a hydraulic system of the earth-moving machine.
Patent CA-2334467-C (CA)
Title: Herbicidal mixture containing a 3 heterocyclyl-substituted benzoyl derivative
Inventor: BERGHAUS RAINER
IPC: C05G3/60
Filed: 1999-05-27
Granted: 2008-02-12
Abstract: Herbicidal mixture containing a) a herbicidally effective amount of a 3 heterocyclyl-substituted benzoyl derivative of formula (I), wherein the variables have the following meanings: R1, R2 = hydrogen, halogen, C1-C6 alkyl, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 halogen alkyl, C1-C6 alkoxy, C1-C6 halogenalkoxy; R3 = hydrogen, halogen, C1-C6 alkyl; X = a heterocycle from the group of isoxazolyl, 4,5-dihydroisoxazolyl and thiazolyl, whereby said heterocycle can be substituted once or more with halogen, C1-C6 alkyl, C1-C4 alkoxy, C1-C4 halogenalkyl, C1-C4 halogenalkoxy, C1-C4 alkylthio; R4 = a cross-linked pyrazol in position 4 of formula (II), whereby R5 =  hydrogen or C1-C6 alkyl and R6 = C1-C6 alkyl, or the environmentally compatible salts thereof; b) a fertiliser containing nitrogen in a synergistically effective quantity and c) an adjuvant in a synergistically effective quantity.
Patent CA-2335367-C (CA)
Inventor: CINELLI FABIO
IPC: A61F13/15
Filed: 1999-06-11
Granted: 2005-04-05
Abstract: The present invention relates to a human waste management device (10) for babies, children or adults to be attached to the perianal area of the wearer. The device comprising a bag (11), said bag (11) having an aperture and a skin attachment means surrounding said aperture (21) wherein said skin attachment means meets certain flexibility criteria so as to ensure maintenance of the device in the desired position of the entire period of wear, including circumstances or periods of wear during which the wearer is active, i.e. not bedridden whilst being compatible with the skin and allowing easy and painless application and removal of the device.
Patent CA-2337935-C (CA)
Inventor: KATO KOJI
IPC: A44B13/00
Filed: 2001-02-23
Granted: 2005-02-01
Abstract: A front center opening can be opened and closed by a zip fastener. A hook assembly joins upper ends of the front center opening in a separable way and adjusts a waist size of pants within a fixed range. An adjusting cloth is sewed between one of fastener tapes of the zip fastener and an outer cloth of the front center opening. The adjusting cloth has an overlap to provide an extra length on the waist size of the pants. The hook assembly adjusts the waist size of the pants so as to fit a waist size of a user. The overlap of the adjusting cloth is extended in a specified manner so as to adjust a size of the pants corresponding to a portion lower than the waist of the user.
Patent CA-2339847-C (CA)
Inventor: PARK CHUNG P
IPC: C08J9/38
Filed: 1999-09-16
Granted: 2009-11-24
Abstract: L'invention concerne une composition polymère à alvéoles ouvertes expansées comprenant au moins une polyoléfine linéaire ou linéaire modifiée, au moins 50 % des alvéoles ouvertes, et la taille moyenne des alvéoles étant d'au moins 1 millimètre. Il est préférable que la composition ait un coefficient d'absorption de son tel que défini par ASTM D 1050 de 1 000 Hz, supérieur à 0,15. Dans des mousses préférées, la résistance à l'écoulement de l'air de la composition est inférieure à 800 000 Rayls/m environ.
Patent CA-2342597-C (CA)
Title: Occlusion catheter for the ascending aorta
Inventor: YOZU RYOHEI
IPC: A61F2/958
Filed: 2001-04-03
Granted: 2010-05-25
Abstract: An occlusion catheter for the ascending aorta capable of obstructing the blood flow within the ascending aorta without inserting through the femoral artery. The occlusion catheter is provided with a drug release aperture formed in the region, which is closer to the proximal end of the catheter tube than a balloon on the outer circumference of the distal end and which is to be located in the vicinity of the coronary ostium when the balloon is placed within the ascending aorta. The present occlusion catheter, when inserted directly into the ascending aorta in the vicinity of the heart to obstruct the blood flow therewithin, enables delivery of a cardiac muscle protective drug to the vicinity of the coronary ostium without inserting the occlusion catheter through the femoral artery in the conventional manner.
Patent CA-2343627-C (CA)
Title: Independent dog operating system
Inventor: BRANDT CALVIN J
IPC: B61J3/06
Filed: 2001-04-10
Granted: 2004-03-02
Abstract: A dog carriage for a railway car indexing system for positioning a railway car or a trip of coupled railway cars having railway wheels mounted in and carrying bogey wheel truck frames by engaging and pushing against the bogey wheel truck frames using dogs includes a dog carriage frame moveable along a railroad track, a pair of spaced opposed dogs pivotally attached to the dog carriage frame for pivoting between a lowered position and a raised position to engage a bogey wheel truck frame in the raised position by movement of said dog carriage frame. A bogey wheel truck frame sensing device is carried on the dog carriage and a dog operating system is provided for controlling the position of each of the dogs individually between said lowered and said raised position.
Patent CA-2355886-C (CA)
Title: Substituted oximes and hydrazones as neurokinin antagonists
Inventor: SHIH NENG-YANG
IPC: A61P25/06
Filed: 1999-12-21
Granted: 2006-10-31
Abstract: Compound represented by structural formula (I) or a pharmaceutical acceptabl e salt thereof, wherein a is 0-3; b, d and a are 0-2; R is H, alkyl, F or -OR6; A is an optionally substituted oxime or hydrazone; d is not 0 and X is a bond, -C(O)-, -O-, -NR9-, -S(O)S, -N(R6)C(O)-, -C(O)N(R6)-, -OC(O)NR6-, -OC(=S)NR6-, -N(R6)C(=S)O-, -S(O)2N(R6 )- , -N(R6)S(O)2-, -N(R6)C(O)O-, -OC(O)- or -N(R6)C(O)NR7-; or d is 0 and X is a bond or -NR6 ; T is H, aryl, heterocycloalkyl or heteroaryl; Q is phenyl, napthyl or heteroaryl; R6 is H, alkyl, hydroxyalkyl, alkoxyalkyl, phenyl, and benzyl; R9 is R6 or -OR6, R6a, R7a, R8a and R9a are H or alkyl; Z is a nitrogen-containing heterocyclo group, e.g., piperidinyl, substituted by a heterocyclo- or heterocycloalkyl group; wherein phenyl, benzyl, aryl, heterocycloalkyl, heteroaryl and cycloalkyl groups are optionally substituted; methods of treating diseases such as asthma, cough, bronchospasm, depression, emesis, inflammatory diseases, and gastrointestinal disorders with said compounds, and pharmaceutical compositions comprising said compounds are disclosed.
Patent CA-2359244-C (CA)
Title: Diphenyle urees a substitution .omega.-carboxy aryle en tant qu'inhibiteurs de la kinase p38
Inventor: RIEDL BERND
IPC: A61K31/496
Filed: 2000-01-13
Granted: 2013-10-08
Abstract: L'invention porte sur le traitement de maladies à médiation p38 au moyen d'un groupe d'aryle urées et sur des compositions pharmaceutiques destinées à un tel traitement.
Patent CA-2361774-C (CA)
Title: Bande preformee et procede d'epissage de courroies de transporteur
Inventor: GEHRETT LARRY JAMES
IPC: B65G15/36
Filed: 1999-03-10
Granted: 2007-11-13
Abstract: Cette invention concerne une bande préformée (20) en caoutchouc non vulcanisé, qui comporte plusieurs rainures (22) destinées à recevoir des torons, dans le but d'y joindre par épissage les extrémités (11, 12) de courroies de transporteur en caoutchouc (10) renforcées par des torons ou des câbles d'acier, cette invention concernant également un procédé de formation d'une telle jointure ainsi épissée.
Patent CA-2364381-C (CA)
Inventor: MATEER DAVID G
IPC: B01L7/00
Filed: 2000-12-20
Granted: 2009-03-10
Abstract: A system for performing hybridization assays comprises a cartridge for housing a flow through device, where the cartridge includes a test fluid chamber for facilitating a substantially uniform floe of a test fluid mixture through the flow through device, and a fluidics station to deliver the test fluid mixture to the cartridge. The cartridge has a chip holder that holds the flows-through device, which has an array of microchannel passages.  The chip holder has a support for placement of the flow though device, the test fluid chamber for directing a substantially uniform flow through device, and a first port that receives the test fluid mixture. The cartridge has a sealing system for preventing the leakage of the test fluid around the flow through device. The test fluid chamber is defined in part by a spade-like surface having an inlet for the test fluid mixture.
Patent CA-2369180-C (CA)
Title: Oriented biopolymeric membrane
Inventor: YUEN DEBBIE
IPC: A61L27/24
Filed: 2000-04-06
Granted: 2010-01-05
Abstract: A sheet membrane containing a layer of oriented biopolymeric fibers. The membrane has a thickness of 0.1 mm to 3.0 mm, a density of 0.1 g/cm3 to 1.2 g/cm3, a hydrothermal shrinkage temperature of 50.degree .C to 85.degree.C, a suture pullout strength of 0.1 kg to 5 kg, a tensile strength of 10 kg/cm2 to 150 kg/cm2, and permeability to molecules having molecular weights of 200 to 300,000 daltons.
Patent CA-2369672-C (CA)
Title: Transgenic animals expressing salivary proteins
Inventor: FORSBERG CECIL W
IPC: C07K16/40
Filed: 2000-04-20
Granted: 2010-06-22
Abstract: The invention provides a transgenic animal having within its genome a transgene construct for gastrointestinal tract specific expression of a protein. In a preferred embodiment, the protein is a phytase or a homologue thereof. Such proteins may be heterologous and may be specifically expressed in the salivary gland of the animal by operably linking the nucleic acid sequence encoding the protein with regulatory sequence including a salivary gland protein promoter/enhancer. Also provided are methods of expressing and producing proteins using such nucleic acid constructs. Further, antibodies specific to such proteins and immunological diagnostic kits are also provided.
Patent CA-2372337-C (CA)
Title: In-pipe wastewater treatment system
Inventor: JOWETT E CRAIG
IPC: C02F9/14
Filed: 2002-02-20
Granted: 2011-04-19
Abstract: In place of the conventional aerobic treatment station, wastewater undergoes aeration in a treatment- pipe. The treatment-pipe has a long/narrow configuration. Open-cell foam serves as treatment material, in the treatment pipe, and promotes attachment of microbial colonies. Two or more treatment-pipes may be connected in series or parallel. Also, in place of a conventional septic tank, wastewater undergoes anaerobic treatment and settlement in a treatment-pipe. The treatment-pipe has a long/narrow configuration. End chambers provide inlet and outlet ports, a sump for collecting settled-out solids, and sealing attachments for the treatment-pipe itself.
Patent CA-2378246-C (CA)
Title: Sterilization of biological tissue
Inventor: GIRARDOT JEAN-MARIE
IPC: A61L27/00
Filed: 2000-08-10
Granted: 2010-06-29
Abstract: Allograft tissue prostheses, as well as tissue valves for replacement of defective heart valves and other tissue-engineered products (TEPs), are effectively sterilized by treatment with a coupling agent known to create amide linkages between amines and carboxylic acids in the presence of a protecting agent. The sterilization treatment preferably employs EDC as a water-soluble coupling agent, plus a water-soluble protecting agent which complexes with potentially reactive amine or carboxyl moieties on the biological tissue, in the optional presence of isopropanol or an equivalent alkanol. One preferred sterilization treatment process uses a buffered aqueous solution where a hydroxymonoamine buffer, such as TRIS plus ethanolamine, provides both the buffering effect and the protecting agents, effectively complexing with potentially reactive carboxyl moieties on the tissue. The treatment is particularly advantageous for sterilizating fresh biological tissue where substantial cross-linking that would alter physical properties of the tissue is undesirable or any tissues or TEPs where a controllable amount of cross-linking is desired.
Patent CA-2378802-C (CA)
Title: Inactivated vaccine against feline calicivirus disease
Inventor: POULET HERVE
IPC: C12P21/08
Filed: 2000-07-13
Granted: 2012-01-24
Abstract: The invention concerns immunogenic preparations and vaccines, in particular inactivated, efficient against feline calicivirus disease, based on strain 431 FCV virus as filed at the CNCM under access number CNCM 1-2166, or one of its equivalents, in a carrier or excipient acceptable in veterinary medicine, preferably associated with the FCV virus derived from another FCV strain, in particular the G1 strain as filed at the CNCM under access number CNCM I-2167. The invention also concerns the hybridoma filed under access number CNCM I-2282, and the monoclonal antibody produced by said hybridoma.
Patent CA-2380569-C (CA)
Inventor: RUDOLPH RAINER
IPC: C07K19/00
Filed: 2000-07-31
Granted: 2008-01-22
Abstract: L'invention concerne un polypeptide chimérique composé d'une première et d'une deuxième chaîne polypeptidique chimiquement liées par l'intermédiaire de 1 à 3 ponts disulfurés à base de cystéine. Cette invention est caractérisée en ce que ladite première chaîne polypeptidique est composée de 1 à 3 cystéines et de 4 à 12 acides aminés de base, de préférence sélectionnés dans le groupe comportant l'arginine, la lysine, et l'ornithine, en ce que ladite deuxième chaîne polypeptidique est composée de 1 à 3 cystéines et de 4 à 12 acides aminés de base, sélectionnés dans le groupe comportant le glutamate et l'aspartate, et en ce que chacune desdites chaînes polypeptidiques est liée au niveau de sa terminaison C ou N à un composé biologiquement actif. Le polypeptide chimérique selon l'invention est utile en tant qu'agent pharmaceutique multimérique.
Patent CA-2381721-C (CA)
Title: Range hood cleaning assembly
Inventor: YEUNG PETER
IPC: F24C15/20
Filed: 2002-04-12
Granted: 2009-01-06
Abstract: A range hood having a cleaning assembly utilizing compressed air to drive accumulated grease on range hood surfaces towards drainage holes. A plurality of air dispensers, preferably air hoses and directional nozzles, through which compressed air from at least one source of compressed air is blown, direct compressed air against surfaces within a motor housing interior, on the fan(s) and within grease trays to drive accumulated grease towards drainage holes. The air dispensers may be attached to a plate mounted within the motor housing interior about a motor and above a fan, may be integral or releasably attachable to the motor housing or may be integral or releasably attachable to grease trays. The compressor may be set to activate automatically or may be activated manually.
Patent CA-2383434-C (CA)
Title: Device and method for facilitating hemostasis of a biopsy tract
Inventor: CHI SING EDUARDO
IPC: A61B17/03
Filed: 2000-08-04
Granted: 2008-10-07
Abstract: A biopsy cannula (16), and a delivery catheter (90) are configured to deliver one or more of an absorbable sponge pledget (18) to a biopsy site after removal of one or more tissue samples from the site. A side port (94) of the delivery catheter (90) is arranged to delive the pledget (18) through the side port of the biopsy cannula (16). <IMG>
Patent CA-2387143-C (CA)
Title: Systeme therapeutique transdermique a base d'hydrochlorure de tulobuterol utilise pour administrer le bronchodilatateur tulobuterol par l'intermediaire de la peau
Inventor: BRACHT STEFAN
IPC: A61K31/135
Filed: 2000-10-06
Granted: 2009-06-02
Abstract: L'invention concerne un système thérapeutique transdermique comprenant une couche de base dans une large mesure perméable à la vapeur d'eau, au moins une couche matricielle contenant le principe actif tulobutérol, ainsi qu'une couche de protection détachable. Ce système se caractérise en ce que la matrice est à base de colles contact de polyacrylate et en ce qu'elle contient comme principe actif du tulobutérol sous forme de son sel hydrochlorure de tulobutérol.
Patent CA-2390681-C (CA)
Inventor: SKAHILL MICHAEL P
IPC: B23Q11/08
Filed: 2002-06-14
Granted: 2006-03-21
Abstract: A break away barrier utilizes first and second spaced apart upstanding posts positioned a predetermined safe distance away from the outer movement limit of a robot. A pair of barrier assemblies are hinged to the first and second spaced apart upstanding posts and are hinged for movement from a closed position inside the safe distance to an open position outside the safe distance. A break away latch permits the opening and separation of the first and second barriers in response to a predetermined force.
Patent CA-2396258-C (CA)
Inventor: FAOUR JOAQUINA
IPC: A61K9/28
Filed: 2001-01-08
Granted: 2008-05-13
Abstract: A delivery device [(1) in Figure 1a] capable of delivering one or more activ e substances by diffusion through plural micropores in the membrane (4) or by osmotic pumping through one or more performed passageways (5) in the membrane is provided. The device (1) contains a centrally located expandable core (2) completely surrounded by an active substance containing layer (3), which is completely surrounded by the membrane (4). The device is capab le of delivering insoluble, slightly soluble, sparingly soluble and very soluble active substances to an environment of use. The preferred delivery rate is zero order. The device can deliver an active substance for a period of about 12-24 hours.
Patent CA-2396337-C (CA)
Inventor: HICKEY TIMOTHY P
IPC: B65D83/00
Filed: 2000-12-11
Granted: 2009-04-28
Abstract: An applicator (10) for dispensing adhesive material (30) includes a container body (20) holding the adhesive material and an applicator tip (60) configured to permit improved control and economy in application of the adhesive. A filter or porous body (50) is fitted in the path of the dispensed adhesive and may contain polymerization and/or cross-linking inhibitors for the adhesive material. The dispenser is particularly suitable for the application of cyanoacry-late adhesive.
Patent CA-2403929-C (CA)
Inventor: RAN XIAOLONG
IPC: H04B1/707
Filed: 2001-01-12
Granted: 2008-09-23
Abstract: The invention relates to a cell initial search method for user equipment (UE) in a CDMA digital cellular mobile communication system. The method includes: a UE after selecting a working frequency point, obtains downlink synchronization with the base station; and corrects carrier deviation between the UE and the base station. The downlink synchronization includes: deciding a range of downlink training sequence timeslot (DwPTS) based on training sequence power characteristic window value method; solving correlation of received data and training sequence in the range to obtain accurate receiving position of a UE. The correction of carrier deviation between a UE and the base station includes: estimating carrier deviation between a UE and the base station by software, recovering carrier frequency difference by using decision and feedback method to adjust hardware and carrier deviation correction method based on joint detection to correct carrier deviation.
Patent CA-2415378-C (CA)
Inventor: CASTAN CATHERINE
IPC: A61K47/14
Filed: 2001-07-10
Granted: 2010-03-16
Abstract: The invention concerns a galenic system with prolonged/controlled release of the medicinal and/or nutritional active principle, for oral administration. The aim is to provide a system enabling to obtain with one single tolerable and acceptable dose of active principle, efficient therapeutic protection over 24 hours (increasing the bioabsorption time without affecting bioavailability). To achieve this, the invention provides a composition comprising two controlled release systems associated in series, namely: individualised coated particles (microcapsules) of active principle forming an internal phase, the coating comprising a film-forming polymer P1 (ethylcellulose), a nitrogenous polymer (polyvinylpyrrolidone), a softener (castor oil) and a lubricant (magnesium stearate), and an external phase of functional carriers: polyelectrolytic hydrophilic polymer: (alginate), neutral hydrophilic polymer (hydroxypropylmethylcellulose) and a gelling additive (calcium acetate), said composition spontaneously forming in the presence of water, a cohesive and stable composite macroscopic solid, wherein the external continuous phase is a gelled matrix including the active principle microcapsules. The invention is useful for delayed oral galenic formulation of metformin.
Patent CA-2418842-C (CA)
Inventor: STEVANOVIC DRAGAN
IPC: F28D17/02
Filed: 2001-08-07
Granted: 2008-08-05
Abstract: A method and apparatus for converting thermal energy into mechanical work, whereby first (4) and second devices (9) for storing thermal energy are alternately connected into a turbine branch (T). In order to increase efficiency, a compressed oxidizing gas (11) is cooled to a second temperature T2 before passing through the first device (4) for storing thermal energy, and the oxidizing gas is then increased, in one step, to a third temperature T3 when passing through the first device (4) for storing thermal energy.
Patent CA-2424703-C (CA)
Title: Explosion-proof hot water heater with unsealed fuel combustion chamber
Inventor: LESAGE CLAUDE
IPC: F24H9/20
Filed: 2003-04-08
Granted: 2009-06-09
Abstract: An explosion-proof hot water heater of the type having a gas-fired combustion chamber at a lower end of the inner tank is described. The combustion chamber is an unsealed chamber and has a sealed bottom wall and a fuel burner in the combustion chamber. Combustion air intake ports are provided about the combustion chamber above the sealed bottom wall. A support base supports the sealed bottom wall elevated from a support surface. Air intake openings are provided about the outer skin casing of the hot water tank and spaced a predetermined distance above the sealed bottom wall. Air passages communicate the air intake openings with the combustion air intake ports of the combustion chamber. A gas vapour sensor is secured in relation to the support base below the sealed bottom wall and is adapted to cause the burner to be shut off upon detection of explosive vapours with sufficient time delay before such vapours reach the combustion chamber.
Patent CA-2426283-C (CA)
Title: Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
Inventor: WILSON JAMES M
IPC: C12P19/34
Filed: 2003-04-22
Granted: 2006-06-27
Abstract: A method for isolating AAV viruses from cellular DNA of non-human primate (NHP) tissues by transfecting the DNA of NHP into 293 cells, rescuing the virus and amplifying it through serial passages in the presence of adenovirus helper functions is provided. This method is useful for isolating novel AAVs and other helper dependent integrated viruses from tissue. Also provided are kits useful for performing this method.
Patent CA-2431311-C (CA)
Inventor: HARDT DICK C
IPC: G06F21/45
Filed: 2003-06-06
Granted: 2004-05-04
Abstract: A system and methods for identity management and authentication are provided herein. The present invention employs shadow domains to prove entity membership in an identity management system where responsibility for trust relationships is devolved to the user. The present invention additionally teaches doubly signed certificate transmission for authentication of assertions made by third parties in the identity management network.